Las Vegas Review-Journal

The murky perils of quitting antidepres­sants

- By Benedict Carey and Robert Gebeloff New York Times News Service

Victoria Toline would hunch over the kitchen table, steady her hands and draw a bead of liquid from a vial with a small dropper. It was a delicate operation that had become a daily routine — extracting ever tinier doses of the antidepres­sant she had taken for three years, on and off, and was desperatel­y trying to quit.

“Basically that’s all I have been doing — dealing with the dizziness, the confusion, the fatigue, all the symptoms of withdrawal,” said Toline, 27, of Tacoma, Washington. It took nine months to wean herself from the drug, Zoloft, by taking increasing­ly smaller doses.

“I couldn’t finish my college degree,” she said. “Only now am I feeling well enough to try to re-enter society and go back to work.”

Long-term use of antidepres­sants is surging in the United States, according to a new analysis of federal data by The New York Times. Some 15.5 million Americans have been taking the medication­s for at least five years. The rate has almost doubled since 2010, and more than tripled since 2000.

Nearly 25 million adults, like Toline, have been on antidepres­sants for at least two years, a 60 percent increase since 2010.

The drugs have helped millions of people ease depression and anxiety, and are widely regarded as milestones in psychiatri­c treatment. Many, perhaps most, people stop the medication­s without significan­t trouble. But the rise in longtime use is also the result of an unanticipa­ted and growing problem: Many who try to quit say they cannot because of withdrawal symptoms they were never warned about.

Some scientists long ago anticipate­d that a few patients might experience withdrawal symptoms if they tried to stop — they called it “discontinu­ation syndrome.” Yet withdrawal has never been a focus of drugmakers or government regulators, who felt antidepres­sants could not be addictive and did far more good than harm.

The drugs initially were approved for short-term use, following studies typically lasting about two months. Even today, there is little data about their effects on people taking them for

 ?? RUTH FREMSON / THE NEW YORK TIMES ?? Victoria Toline needed nine months in 2014 to taper off the drug Zoloft. Many people on antidepres­sants quit without much trouble, but withdrawal reactions are a common problem and have contribute­d to soaring rates of long-term antidepres­sant use. “I...
RUTH FREMSON / THE NEW YORK TIMES Victoria Toline needed nine months in 2014 to taper off the drug Zoloft. Many people on antidepres­sants quit without much trouble, but withdrawal reactions are a common problem and have contribute­d to soaring rates of long-term antidepres­sant use. “I...

Newspapers in English

Newspapers from United States